Gilead Sciences Inc’s massive hepatitis C franchise is fading, the company warned on Tuesday, projecting that sales this year could be just two-thirds of what investors had been expecting.
Revenue from the company’s drugs for the viral infection would be US$7.5 billion to US$9 billion this year, Gilead said in a statement.
That is far below the US$11.6 billion analysts had projected, according to data compiled by Bloomberg. The company sells three main hepatitis C treatments — Sovaldi, Harvoni and Epclusa.
“This is a challenging situation,” Gilead Sciences chief executive officer John Milligan said during a conference call with analysts, adding that the hepatitis C market is “declining faster this year than we would have predicted last year.”
The shares fell after the new projection, and on Tuesday were down 5.4 percent to US$69.20 per share at 6:31pm in New York.
The hepatitis C pills — which have cut treatment times and side effects compared with older medicines — were the biggest drug launch of all time and are still massive products for the Foster City, California, company.
However, competitors Merck & Co and AbbVie Inc have cut into Gilead’s market share, forcing prices down and the bulk of the easiest-to-find patients might already have been treated, meaning that sales are expected to continue to decline.
The average US price of a one-month supply of Harvoni after discounts and rebates was less than US$15,000 last year, Milligan said.
For patients taking three months of treatment, that would be more than 52 percent off the list price of US$94,500.
Competition and shorter treatment duration for patients would reduce sales this year by US$1.9 billion to US$2.5 billion from last year’s figure, while fewer new patients starting on the drugs would mean US$2.9 billion to US$3.8 billion less in this year’s sales, Gilead said in a presentation released along with the projections.
While investors fret over what would replace the hepatitis C drugs, Gilead has said it wants to use acquisitions to fill its product pipeline.
However, it announced no new major deals and instead increased its dividend by more than 10 percent.
Milligan acknowledged that it would be “challenging to grow without some sort of acquisition” outside of the HIV franchise, and the firm’s chief financial officer Robin Washington said the company would focus on pursuing external opportunities in the coming year.
HORMUZ ISSUE: The US president said he expected crude prices to drop at the end of the war, which he called a ‘minor excursion’ that could continue ‘for a little while’ The United Arab Emirates (UAE) and Kuwait started reducing oil production, as the near-closure of the crucial Strait of Hormuz ripples through energy markets and affects global supply. Abu Dhabi National Oil Co (ADNOC) is “managing offshore production levels to address storage requirements,” the company said in a statement, without giving details. Kuwait Petroleum Corp said it was lowering production at its oil fields and refineries after “Iranian threats against safe passage of ships through the Strait of Hormuz.” The war in the Middle East has all but closed Hormuz, the narrow waterway linking the Persian Gulf to the open seas,
RATIONING: The proposal would give the Trump administration ample leverage to negotiate investments in the US as it decides how many chips to give each country US officials are debating a new regulatory framework for exporting artificial intelligence (AI) chips and are considering requiring foreign nations to invest in US AI data centers or security guarantees as a condition for granting exports of 200,000 chips or more, according to a document seen by Reuters. The rules are not yet final and could change. They would be the first attempt to regulate the flow of AI chips to US allies and partners since US President Donald Trump’s administration said it rescinded its predecessor’s so-called AI diffusion rules. Those rules sought to keep a significant amount of AI
Apple Inc increased iPhone production in India by about 53 percent last year and now makes a quarter of its marquee devices there, reflecting the US company’s efforts to avoid tariffs on China. The company assembled about 55 million iPhones in India last year, up from 36 million a year earlier, people familiar with the matter said, asking not to be named because the numbers aren’t public. Apple makes about 220 million to 230 million iPhones a year globally, with India’s share of the total increasing rapidly. Apple has accelerated its expansion in the world’s most populous country in recent years, bolstered
HEADWINDS: The company said it expects its computer business, as well as consumer electronics and communications segments to see revenue declines due to seasonality Pegatron Corp (和碩) yesterday said it aims to grow its artificial intelligence (AI) server revenue more than 10-fold this year from last year, driven by orders from neocloud solutions clients and large cloud service providers. The electronics manufacturing service provider said AI server revenue growth would be driven primarily by the Nvidia Corp GB300 server platform. Server shipments are expected to increase each quarter this year, with the second half likely to outperform the first half, it said. The AI server market is expected to broaden this year as more inference applications emerge, which would drive demand for system-on-chip, application-specific integrated circuits
RSS